Software Treatment for Actively Reducing Severity of ADHD - Follow Up
NCT ID: NCT02828644
Last Updated: 2019-02-12
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
175 participants
INTERVENTIONAL
2016-08-31
2018-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Software Treatment for Actively Reducing Severity of ADHD
NCT02674633
Cognitive ADHD Videogame Exploratory Study
NCT01943539
Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD
NCT06215144
An Adjunct Study to Assess Guided ADHD Therapy for Managing the Extent and Severity of Symptoms
NCT05805176
Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant
NCT03649074
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The trial will consist of 4 visits: Screening (to be conducted at the same time as the end-of-study visit for the parent study Akili-001R), FU-Day 28 visit (conducted in clinic), and FU-Day 56 and FU-Day 84 visits (conducted remotely via electronically captured parent reported outcomes).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EVO Multitasking
EVO Multitasking is a digital intervention that requires subjects to navigate a character through a game-like space, while collecting objects, in a fixed period of time. The intervention was administered to the subjects during the parent study (Akili-001R)
EVO
videogame-like digital therapy
EVO Words
EVO Words is a digital intervention that requires subjects to spell as many words as possible, by connecting letters in a game-like grid, in a fixed period of time. The intervention was administered to the subjects during the parent study (Akili-001R)
EVO
videogame-like digital therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EVO
videogame-like digital therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to comply with all the testing and requirements per this protocol
Exclusion Criteria
* Participant has demonstrated clinically significant deterioration in functioning as assessed by PI and other study staff that would contraindicate continued participation in the follow-up study
8 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Akili Interactive Labs, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Scott Kollins, PhD
Role: PRINCIPAL_INVESTIGATOR
Duke Clinical Research Institution
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Melmed Center
Scottsdale, Arizona, United States
Avida, Inc.
Newport Beach, California, United States
University of California Davis MIND Institute
Sacramento, California, United States
Florida Clinical Research Center, LLC
Bradenton, Florida, United States
Florida Clinical Research Center, LLC
Bradenton, Florida, United States
Meridien Research
Bradenton, Florida, United States
Florida Clinical Research Center
Maitland, Florida, United States
South Shore Psychiatric Services
Marshfield, Massachusetts, United States
Midwest Research Group
Saint Charles, Missouri, United States
Center for Psychiatry and Behavioral Medicine
Las Vegas, Nevada, United States
Duke Child and Family Study Center
Durham, North Carolina, United States
Duke University
Durham, North Carolina, United States
The Neuropsychiatric Clinic at Carolina Partners
Raleigh, North Carolina, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Seattle Children's
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Akili-001R-FollowUp
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.